跳至主要内容
临床试验/ISRCTN13984129
ISRCTN13984129已完成不适用

Optimal Lag Time Study: Optimal timing of rapid-acting insulin analogues administration before meals

Academic Medical Centre (AMC) (Netherlands)0 个研究点目标入组 10 人开始时间: 2010年3月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Men or women aged from 18 to 75 years
  • 2. Type 1 diabetes according to the WHO definition
  • 3. Treated with insulin for at least 2 years and by Continuous Subcutaneous Insulin Infusion (CSII) for at least 6 months
  • 4. Body mass index (BMI) < 35 kg/m2
  • 5. Written informed consent

排除标准

  • 1. Pregnancy (women of childbearing potential must have an adequate contraception) or
  • breastfeeding
  • 2. Treatment with systemic corticosteroids
  • 3. Treatment with oral antidiabetics within 1 week prior to the first study day
  • 4. Impaired renal function as shown by serum creatinine = 133 umol/l in men or = 124 umol/l in women
  • 5. Known impaired hepatic function defined as alanine aminotransferase (ALAT) and / or aspartamine aminotransferase (ASAT) three times greater the upper limit of the normal range
  • 6. Alcohol or drug abuse in the last year
  • 7. Mental condition rendering the patient unable to understand the nature and scope of the

研究者

发起方
Academic Medical Centre (AMC) (Netherlands)

相似试验